EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reduction of butyrate-producing bacteria in the gut microbiome of Japanese patients with pancreatic cancer

Makoto Sono, Kei Iimori, Munemasa Nagao, Satoshi Ogawa, Takahisa Maruno, Yuki Nakanishi, Takayuki Anazawa, Kazuyuki Nagai, Toshihiko Masui, Hiroshi Mori, Koji Hosomi, Jun Kunisawa und 6 weitere

Pancreatology · 2024

DOI: 10.1016/j.pan.2024.09.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2024. Verfasst von Makoto Sono und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Jap…. Hauptthemen laut MEDLINE: Butyrates, Gastrointestinal Microbiome, Pancreatic Neoplasms, RNA, Ribosomal, 16S. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Co-creation place formation support program, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The incidence of pancreatic cancer is on the rise, and its prognosis remains poor. Recent reports have established a link between the gut and oral microbiome and pancreatic cancer. However, the intricacies of this association within the Japanese population remain unclear. In this study, we investigated the gut and oral microbiomes of Japanese patients with pancreatic cancer, comparing them with those of healthy individuals. METHODS: We recruited 30 patients with untreated pancreatic cancer and 18 healthy controls at Kyoto University Hospital (2018-2022). We performed a comprehensive 16S rRNA gene sequencing to analyze their gut and oral microbiomes. RESULTS: Analysis revealed that the diversity of the gut and oral microbiomes of patients with pancreatic cancer was reduced compared to that of the healthy controls. Specifically, we observed an increase in the genus Streptococcus in both the gut and oral microbiomes and a significant decrease in several butyrate-producing bacteria in fecal samples. Moreover, bacteria such as Streptococcus mitis and Holdemanella biformis were present in pancreatic cancer tissues, suggesting that they might influence the carcinogenesis and progression of pancreatic cancer. CONCLUSIONS: The gut and oral microbiome differed between patients with pancreatic cancer and healthy controls, with a notable decrease in butyrate-producing bacteria in the gut microbiome of the patients. This suggests that there may be a distinct microbial signature associated with pancreatic cancer in the Japanese population. Further studies are required to elucidate the microbiome's causal role in this cancer and help develop prognostic markers or targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ButyratesGastrointestinal MicrobiomePancreatic NeoplasmsRNA, Ribosomal, 16SAgedAged, 80 and overFemaleHumansMaleMiddle AgedBacteriaCase-Control StudiesEast Asian PeopleFecesJapanMouth

Stichwörter der Autor:innen

Butyrate-producing bacteriaDysbiosisGut microbiomeMicrobial signatureOral microbiomePancreatic cancerShort-chain fatty acid

Substanzen

ButyratesRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Department of Informatics, National Institute of Genetics, 1111 Yata, Mishima, Shizuoka, 411-8540, Japan.
  • Laboratory of Vaccine Materials and Laboratory of Gut Environmental System, Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Asagi, I…
  • Biofermin Pharmaceutical Co., Ltd., 7-3-4 Higashi-machi, Ibukidai, Nishi-ku, Kobe, 651-2242, Japan.
  • Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. Electronic address: fukuda26@kuhp.kyoto-u.ac.jp.

Förderung

  • Co-creation place formation support program
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency
  • Japan Science and Technology Agency Moonshot Research and Development Program
  • Core Research for Evolutional Science and Technology

Zitieren

APA

Sono, M., Iimori, K., Nagao, M., Ogawa, S., Maruno, T., Nakanishi, Y., Anazawa, T., Nagai, K., Masui, T., Mori, H., Hosomi, K., Kunisawa, J., Yokota, H., Tanaka, Y., Ohno, H., Hatano, E., Fukuda, A., & Seno, H. (2024). Reduction of butyrate-producing bacteria in the gut microbiome of Japanese patients with pancreatic cancer. Pancreatology. https://doi.org/10.1016/j.pan.2024.09.002

Vancouver

Sono M, Iimori K, Nagao M, Ogawa S, Maruno T, Nakanishi Y, et al. Reduction of butyrate-producing bacteria in the gut microbiome of Japanese patients with pancreatic cancer. Pancreatology. 2024. doi:10.1016/j.pan.2024.09.002

BibTeX
@article{Sono2024,
  author = {Sono, Makoto and Iimori, Kei and Nagao, Munemasa and Ogawa, Satoshi and Maruno, Takahisa and Nakanishi, Yuki and Anazawa, Takayuki and Nagai, Kazuyuki and Masui, Toshihiko and Mori, Hiroshi and Hosomi, Koji and Kunisawa, Jun and Yokota, Haruka and Tanaka, Yoshiki and Ohno, Hiroshi and Hatano, Etsuro and Fukuda, Akihisa and Seno, Hiroshi},
  title = {Reduction of butyrate-producing bacteria in the gut microbiome of Japanese patients with pancreatic cancer},
  journal = {Pancreatology},
  year = {2024},
  doi = {10.1016/j.pan.2024.09.002}
}
Kostenlos starten →